Pilot open label clinical trial of oral ruxolitinib in patients with alopecia areata

GSE80342

Homo sapiens

27 Downloadable Samples

Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)

Submitter Supplied Information

Description

This goal of these studies were to examine gene expression profiles of skin from patients with alopecia areata undergoing treatment with oral ruxoltinib.

PubMed ID

27699253

Publication Title

Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata.

Total Samples

Submitter’s Institution

Columbia University

Authors

Mackay-Wiggan J, Jabbari A, Nguyen N, Cerise JE, Clark C, Ulerio G, Furniss M, Vaughan R, Christiano AM, Clynes R

Source Repository

Gene Expression Omnibus (GEO)

Alternate Accession IDs

E-GEOD-80342

No rows found